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Abstract
Background: Canine vector-borne diseases (CVBD) have become a major concern for canine and human public
health. The aim of the study described here is to add epidemiological data regarding four pathogens responsible
for CVBD, namely anaplasmosis, borreliosis, dirofilariosis and ehrlichiosis in a national survey conducted in Mexico.
Methods: Seventy-four veterinary centres located in 21 federal Mexican states were asked to test dogs with clinical
signs suspect for CVBD and healthy dogs, for detection of Dirofilaria immitis antigen and antibodies against
Anaplasma spp., Borrelia burgdorferi (sensu lato) and Ehrlichia canis using the SNAP® 4DX® from IDEXX® Laboratories.
Results: A total of 1706 dogs were tested, including 943 apparently healthy and 722 CVBD-suspect dogs. Infected
dogs were 36.7 %. The highest percentages of infection with E. canis (51.0 %) and Anaplasma spp. (16.4 %) were
obtained in the northwestern region, while D. immitis was most frequently found in the northeastern region of the
country (8.9 %). Four dogs from the northwestern, northeastern, eastern and southeastern regions, respectively,
were positive for B. burgdorferi (sensu lato). Northcentral regions showed lowest overall prevalence of infection
(2.4 %). Co-infections were detected in 8.8 % of the dogs tested. Statistically significant lower positivity was found
among dogs aged less than one year (23.2 %) and small-sized dogs (27.6 %), while higher prevalence of infection
was found in dogs living outdoors (42.0 %), dogs with detectable tick infestation (43.3 %) and dogs that received
treatment for tick-transmitted infections (58.8 %). Seropositivity was a risk factor for the presence of clinical signs as
follows: Anaplasma spp. (OR = 2.63; 95 % CI: 1.88–3.67; P < 0.0001), D. immitis (OR = 2.52; 95 % CI: 1.61–3.95; P < 0.
0001), E. canis (OR = 3.58; 95 % CI: 2.88–4.45; P < 0.0001), mixed infections (OR = 4.08; 95 % CI: 2.79–5.96; P < 0.0001),
one or more agents (OR = 3.58; 95 % CI: 2.91–4.42; P < 0.0001).
Conclusions: Canine serological evidence supports that dogs from Mexico are at risk of acquiring Anaplasma spp.,
D. immitis and/or E. canis, while B. burgdorferi (sensu lato) transmission is minimal in the country. Practitioners play a
fundamental role in the detection and control of these diseases to protect dogs and humans.
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Background
In the last decades, worldwide emergence and reemergence
of many canine vector-borne diseases (CVBD) have been
documented [1–4]. A diverse range of pathogens transmit-
ted by haematophagous arthropods, mainly ticks and mos-
quitoes, cause CVBD [5], which have become a major focus
of interest due to their importance to canine and human
public health. In addition to suffering from illness, dogs can
be subclinically infected and act as reservoir hosts for
arthropod-transmitted zoonotic pathogens [6]. The increasing
canine population and the close relationship with humans
in both rural and urban areas add new concerns [7].
Anaplasmosis, borreliosis, dirofilariosis and ehrlichio-
sis have been recognized as some of the major CVBD
with global significance [8].
Anaplasma phagocytophilum is a Gram-negative obligate
intracellular bacterium, transmitted by ticks of the genus
Ixodes. Anaplasma phagocytophilum infects granulocytes,
mainly neutrophils, causing granulocytic anaplasmosis in
mammalian hosts, including dogs and humans [9]. Ana-
plasma platys, transmitted by R. sanguineus (sensu lato) in-
fects canine platelets and is responsible for the infectious
canine cyclic thrombocytopenia. Pathogenicity is generally
low but A. platys may play a role in co-infection with other
arthropod-borne diseases [10]. The close molecular rela-
tionship between A. phagocytophilum and A. platys limits
the serological differentiation between both agents due to
cross-reactions [11].
Borrelia burgdorferi (sensu lato) is the causative agent
of Lyme disease or borreliosis in mammalian hosts.
Ticks of the genus Ixodes are the main vectors of this
spirochete [12]. Dogs are susceptible to infection but
clinical disease generally is milder and less frequent than
in humans [13]. Because of their frequent exposure to
ticks and ready seroconversion, dogs have been proposed
as sentinels for risk of Lyme disease in humans [14].
Cardiopulmonary dirofilariosis is a potentially fatal dis-
ease caused by infection mainly with the adult stages of
the nematode Dirofilaria immitis, also known as heart-
worm, and mosquitoes of the genus Aedes and Culex are
considered main vectors [15]. Human heartworm infec-
tion is incidental and typically not associated with severe
clinical signs. However, human cases have been reported
in areas of high canine prevalence, highlighting the im-
portance of heartworm testing and chemoprophylaxis in
dogs to reduce transmission [16].
The Gram-negative bacterium Ehrlichia canis is the
causative agent of canine monocytic ehrlichiosis, trans-
mitted worldwide by the brown dog tick Rhipicephalus
sanguineus (sensu lato) [17, 18]. Diagnosis is challenging
due to its different phases and multiple clinical-pathological
manifestations [19, 20].
Prevalence of CVBD is dependent on favourable cli-
mate and habitat for the microbiologic pathogens, their
arthropod vectors and their mammalian reservoirs [2].
Mexico has a great diversity of climates determined by
Fig. 1 Geoeconomic regions of Mexico. Distribution of the federated states of Mexico, according to a geoeconomic division, into eight different
geoeconomic regions as follows: northwestern, northeastern, western, eastern, northcentral, southcentral,southeastern and southwestern
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several factors such as the altitude, geographical latitude,
weather conditions and the existing distribution of land
and water [21]. The existence of favourable environ-
ments for the development of CVBD across the country
has already been demonstrated, but knowledge of the
prevalence and distribution of CVBD in Mexico is scarce
and most data rely on geographically limited studies
and/or the assessment of a low number of pathogens
[22–31].
Epidemiological tools are essential to guide the defini-
tive etiological diagnosis of CVBD and establish ad-
equate methods for prevention [32]. Studies mapping
the national seroprevalence of certain CVBD agents have
been recently conducted in other countries [33–49].
However, to the authors' knowledge, this is the first de-
scription in Mexico at the countrywide level.
This study aimed to add useful information about the
national serological distribution and epidemiological as-
sociations of four important vector-borne pathogens
among dogs from different Mexican states.
Methods
Source of data
Seventy-four veterinary centres located in 28 cities repre-
sented 21 out of 32 Federate Mexican states in this study.
Cities were selected in locations where CVBD agents are
more likely to be found. In order to geographically assess
canine seroprevalence, states were grouped into eight dif-
ferent geoeconomic regions: northwestern (Baja California
Norte, Baja California Sur, Chihuahua, Sinaloa and
Sonora), northeastern (Coahuila and Nuevo Leon),
western (Colima, Jalisco and Nayarit), eastern (Puebla,
Veracruz and Hidalgo), northcentral (Aguascalientes,
Guanajuato and Querétaro), southcentral (Morelos),
southeastern (Quintana Roo and Yucatán) and
southwestern (Chiapas and Guerrero) (Fig. 1).
Each veterinary centre received at least 30 in-clinic
tests. Veterinarians were asked to test dogs with clinical
signs suspect for anaplasmosis, borreliosis, dirofilariosis
and/or ehrlichiosis, and a similar number of apparently
healthy dogs, under physical examination, from April
2011 to January 2012. Inclusion criteria for testing sick
dogs was considered for the presence of one or more of
the following clinical alterations: lethargy, hyperthermia,
weakness, weight loss, oedema, polyuria-polydipsia,
lymph node enlargement, joint inflammation, lameness,
cough, dyspnoea, nasal discharge, pale mucous mem-
branes, haemorrhagic disorders, ocular lesions or neuro-
logic signs. The absence of consistent history and/or
evidence of abnormalities compatible with CVBD were
considered exclusion criteria and these dogs were in-
cluded in the healthy group.
The study was carried out in accordance with the
International Guiding Principles for Biomedical Research
Involving Animals, issued by the Council for the Inter-
national Organizations of Medical Sciences. Dogs were
entered in the study under owner consent. Veterinarians
recorded additional data of the dogs using a questionnaire
Table 1 Population description








Male 486 392 23 901
Female 442 322 17 781
Not known 15 8 1 24
Age
< 1 year 41 36 5 82
≥ 1 year 874 667 29 1570
Not known 28 19 7 54
Median age 4 years 5 years 5 years 5 years




383 234 14 631
Medium
(10–25 kg)
103 121 2 226
Large
(> 25 kg)
304 200 18 522
Not known 153 167 7 327
Lifestyle
Indoors 269 166 12 447
Outdoors 620 516 23 1159
Not known 54 40 6 100
Tick contact
Yes 627 602 29 1258
No 268 68 5 341
Not known 48 52 7 107
TTI prevention
Yes 46 36 3 85
No 890 676 27 1593
Not known 7 10 11 28
MTI prevention
Yes 43 42 0 85
No 891 667 27 1585
Not known 9 13 14 36
Travel history
Yes 176 151 4 331
No 763 569 33 1365
Not known 4 2 4 10
Abbreviations: IQR interquartile range, TTI tick-transmitted infections, MTI
mosquito-transmitted infections
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that included health status, gender, age (< 1 year or ≥
1 year), size [small (< 10 kg), medium (10–25 kg) or large
(> 25 kg)], lifestyle (outdoors or indoors), detectable tick
infestation, use of treatment (mainly tetracycline, doxycyc-
line, imidocarb and/or ivermectin) against tick and
mosquito-transmitted infections as those evaluated here,
and travel history to other regions or abroad.
Serological testing
Whole blood, serum or plasma samples from dogs were
tested by means of a rapid in-clinic enzyme-linked im-
munosorbent assay (ELISA) kit (SNAP® 4Dx® from
IDEXX® Laboratories, Westbrook, Maine, USA), accord-
ing to the instructions listed in the product package in-
sert. This assay screens for simultaneous qualitative
detection of a circulating carbohydrate of D. immitis
antigen, from the adult female heartworms, and anti-
bodies, immunoglobulin G and M, against immunodo-
minant proteins of A. phagocytophylum (p44/MSP2), B.
burgdorferi (sensu lato) (C6) and E. canis (p30 and p30-
1). Preliminary studies indicate that A. phagocytophilum
analyte in SNAP® 4Dx® cross-reacts with samples from A.
platys-infected dogs (SNAP® 4Dx® kit insert, unpublished
data). Reported sensitivity and specificity of the in-
clinic ELISA for detection of antibodies are 99.1 and
100 % for A. phagocytophilum, 98.8 and 100 % for B.
burgdorferi (sensu lato) and 96.2 and 100 % for E.
canis. Reported sensitivity and specificity for detec-
tion of heartworm antigen were 99.2 and 100 %, re-
spectively [50].
Data analysis
Statistical analysis was performed using SPSS 20.0 soft-
ware. Values for prevalence were established. Chi-square
and Fisher’s exact tests were used to compare proportions
of positivity related to categorical dependent variables. A
probability P-value < 0.05 was considered statistically sig-
nificant. Logistic regression analysis was subsequently per-
formed. Significant differences between categories were
quantified calculating odds ratios (OR) and their 95 %
confidence intervals (CI).
Results
Practitioners tested a total of 1706 dogs over the study
period. Information about health status was recorded for
1665 dogs: 943 apparently healthy and 722 CVBD-
suspect dogs; no data were available for 41 dogs. Table 1
summarizes the characteristics of the population.
Overall and regional seroprevalence of all the dogs in-
cluded in the study, apparently healthy dogs and CVBD-
suspect dogs are shown in Tables 2, 3 and 4.




Positivity (%) [95 % CI] Dogs
co-infected (%)
[95 % CI]
A Bb Di Ec
Northwestern 384 213 (55.47)** 63 (16.4)** 1 (0.26) 25 (6.51) 196 (51.04)** 64 (16.67)**
[50.3–60.2] [12.8–20.1] [0.0–0.8] [4.2–9.4] [46.1–56.0] [12.5–20.3]
Northeastern 349 114 (32.66) 23 (6.59)* 1 (0.29) 31 (8.88)* 80 (22.9)** 19 (5.44)*
[27.8–37.5] [4.3–9.2] [0.0–0.8] [6.0–12.0] [18.6–27.5] [3.4–8.0]
Northcentral 164 4 (2.44)** 1 (0.61)** 0 (0) 0 (0)* 4 (2.43)** 1 (0.61)**
[0.6–4.9] [0.0–1.8] [0.0–0.0] [0.0–0.0] [0.6–4.9] [0.0–1.8]
Western 140 54 (38.57) 14 (10) 0 (0) 3 (2.14) 52 (37.14) 15 (10.71)
[30.5–46.4] [5.7–15.0] [0.0–0.0] [0.0–5.0] [28.6–45.0] [5.7–15.7]
Eastern 205 54 (26.34)* 18 (8.78) 1 (0.49) 10 (4.88) 37 (18.05)** 11 (5.37)
[20.5–32.2] [4.9–12.7] [0.0–1.5] [2.0–7.8] [13.0–23.4] [2.4–8.8]
Southcentral 86 17 (19.77)* 4 (4.65) 0 (0) 2 (2.32) 13 (15.12)* 2 (2.32)*
[11.6–29.1] [1.2–9.3] [0.0–0.0] [0.0–5.8] [8.1–23.3] [0.0–5.8]
Southwestern 149 67 (44.97)* 19 (12.75) 0 (0) 2 (1.34)* 63 (42.3)* 16 (10.74)
[36.9–53.0] [7.4–18.8] [0.0–0.0] [0.0–3.4] [34.2–50.3] [6.0–16.1]
Southeastern 229 103 (44.98)* 27 (11.79) 1 (0.44) 18 (7.86) 81 (35.37) 23 (10.04)
[38.4–51.5] [7.4–16.2] [0.0–1.3] [4.8–11.8] [29.3–41.5] [6.6–14.0]
Mexican
states
1706 626 (36.7) 169 (9.91) 4 (0.23) 91 (5.33) 526 (30.83) 151 (8.85)
[34.3–39.0] [8.6–11.4] [0.1–0.5] [4.3–6.4] [28.7–33.1] [7.5–10.2]
Abbreviations: A Anaplasma spp., Bb Borrelia burgdorferi (sensu lato), Di Dirofilaria immitis, Ec Ehrlichia canis
* Statistically significant difference (P < 0.05); ** Statistically significant difference (P < 0.0001) to the corresponding national average value of prevalence
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Of the 1706 dogs tested, 626 (36.7 %) were positive to
one or more agents. The highest prevalence was de-
tected in the Northwest (55.5 %), where seropositivity to
E. canis (51.0 %) and Anaplasma spp. (16.4 %) was sig-
nificantly higher than in the remaining regions. Dirofi-
laria immitis was more frequently detected in the
Northeast (8.9 %). However, seropositivity to B. burgdor-
feri (sensu lato) was similar in the eight regions. Lowest
seroprevalence was observed in the northcentral area of
the country (2.4 %).
Table 5 describes positive results for more than one
agent in 151 of 1706 dogs (8.8 %), mostly between E.
canis and Anaplasma spp. No dog was positive for all
agents.
Seropositivity to the different CVBD agents according
to the variables analysed is shown in Table 6. Odds ra-
tios (OR) and 95 % CI for binomial variables presenting
significant associations are summarized in Table 7. For
all of the dogs examined no association was observed
between gender and any CVBD agent. Overall, dogs
aged 1 year-old or older presented a higher prevalence
(37.0 %) than dogs aged less than 1 year (23.2 %), χ2 =
6.450, df = 1, P < 0.011. Positivity among small-sized dogs
(27.6 %) was significantly lower than positivity for
medium (43.4 %) and large breed dogs (39.8 %), χ2 =
27.676, df = 2, P < 0.001. Prevalence among dogs living
outdoors was higher than indoors (42.0 and 23.7 %,
respectively; χ2 = 46.412, df = 1, P < 0.001). Dogs with
detectable tick contact were more frequently positive
to CVBD agents (43.3 %) than dogs without ticks
(9.7 %), χ2 = 131.577, df = 1, P < 0.001. In addition,
higher prevalence was detected among dogs that re-
ceived treatment for tick-transmitted infections than
dogs that did not (58.8 and 35.6 %, respectively; χ2 =
18.730, df = 1, P < 0.001), while receiving treatment for
mosquito-transmitted infections was not linked to the
presence of CVBD agents. No relationship was detected
between positivity and previous travel history. Seropositiv-
ity was a risk factor for the presence of clinical signs (χ2 =
149.200, df = 1, P < 0.001).
Discussion
Countrywide serological evaluation for four CVBD
agents was carried out in Mexico. The regions described
in the study presented here resulted from a geoeconomic
division of the country. This classification is not coinci-
dental with a climatic division, which according to hu-
midity and temperature categorizes the country into
areas with a warm wet, warm humid, dry, very dry, mild
humid and mild wet climate (Fig. 2) [21].
Seropositivity values for Anaplasma spp., B. burgdor-
feri (sensu lato), D. immitis and E. canis reported here
Table 3 Geographical distribution of seroprevalence to CVBD agents among apparently healthy dogs
Apparently healthy dogs
Region Dogs Dogs infected
(%) [95 % CI]
Positivity (%) [95 % CI] Dogs co-infected
(%) [95 % CI]A Bb Di Ec
Northwestern 177 62 (35.03)** 22 (12.43)** 0 (0) 10 (5.65) 55 (31.07)** 21 (11.86)**
[28.2–41.8] [7.9–17.5] [0.0–0.0] [2.8–9.0] [24.7–37.9] [7.3–16.9]
Northeastern 223 48 (21.52) 6 (2.69)* 0 (0) 13 (5.83)* 33 (14.79) 4 (1.79)
[16.6–26.9] [0.9–4.9] [0.0–0.0] [3.1–9.0] [10.3–19.4] [0.4–3.6]
Northcentral 107 0 (0)** 0 (0)* 0 (0) 0 (0)* 0 (0)** 0 (0)*
[0.0–0.0] [0.0–0.0] [0.0–0.0] [0.0–0.0] [0.0–0.0] [0.0–0.0]
Western 57 19 (33.33) 4 (7.02) 0 (0) 2 (3.51) 17 (29.82) 4 (7.02)
[21.1–45.6] [1.8–14.0] [0.0–0.0] [0.0–8.8] [17.5–42.1] [1.8–14.0]
Eastern 131 26 (19.85) 7 (5.34) 0 (0) 5 (3.82) 17 (12.98) 2 (1.53)
[13.0–27.5] [1.5–9.2] [0.0–0.0] [0.8–7.6] [7.6–19.1] [0.0–3.8]
Southcentral 46 5 (10.87)* 2 (4.35) 0 (0) 0 (0) 4 (8.69) 1 (2.17)
[2.2–20.3] [0.0–10.9] [0.0–0.0] [0.0–0.0] [2.2–17.4] [0.0–6.5]
Southwestern 86 34 (39.53)* 5 (5.81) 0 (0) 0 (0) 32 (37.21)** 3 (3.49)
[29.1–50.0] [1.2–11.6] [0.0–0.0] [0.0–0.0] [27.5–47.7] [0.0–8.1]
South-eastern 116 33 (28.45) 12 (10.35) 0 (0) 1 (0.86) 24 (20.69) 4 (3.45)
[20.7–37.1] [5.2–16.4] [0.0–0.0] [0.0–2.6] [13.8–28.4] [0.9–6.9]
Mexican
states
943 227 (24.07) 58 (6.15) 0 (0) 31 (3.29) 182 (19.30) 39 (4.13)
[21.3–26.8] [4.7–7.6] [0.0–0.0] [2.2–4.5] [16.8–21.8] [3.0–5.5]
Abbreviations: A Anaplasma spp., Bb Borrelia burgdorferi (sensu lato), Di Dirofilaria immitis, Ec Ehrlichia canis
* Statistically significant difference (P < 0.05); ** Statistically significant difference (P < 0.0001) to the corresponding national average value of prevalence
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must be interpreted as current infection with or previous
exposure to the pathogens under assessment.
Positive dogs to Anaplasma spp. were 9.9 %, with the
highest prevalence detected in the northwestern (16.4 %)
and lowest in the northcentral states of the country
(0.6 %). Due to serological cross-reactivity between A.
phagocytophilum and A. platys, results presented here
indicated exposure to Anaplasma spp., but unfortunately
the lack of molecular assessment limited species-level
identification. To our knowledge, this is the first study
documenting seroprevalence of Anaplasma spp. in sev-
eral states of Mexico. To date only anecdotal reports
have documented the presence of Anaplasma spp. in
this country [31, 51]. Seroprevalence detected in the
northeastern region in this study was 6.6 %. This per-
centage is higher than detected previously by ELISA
testing (3 %) among 391 dogs from Monterrey (Nuevo
León) [51]. In contrast, the prevalence of infection for
Anaplasma 16S rRNA obtained by molecular identifica-
tion in a recent study conducted among 100 healthy
dogs infested by ticks, in Coahuila and Durango, was
31 % [31].
The very low B. burgdorferi (sensu lato) seroprevalence
(0.2 %) is one of the more important findings in this
study. Each of the four positive dogs was from the east-
ern, southeastern, northeastern and northwestern region,
respectively. Data were not completely recorded for
these dogs, so if they were strays or pets that had trav-
eled to Lyme endemic regions, it would not be unex-
pected to get such a low seroprevalence with a test with
excellent specificity [50]. Alternatively, these could be
false positives. All of the dogs positive for B. burgdorferi
(sensu lato) presented clinical signs compatible with
CVBD, that finding is in agreement with the fact that
the SNAP 4DX kit could be more sensitive to detect
antibodies during active infection [26], which could not
explain the low seroprevalence recorded here. Low
prevalence (0.9 %) was previously reported among 338
dogs from Nuevo Leon, detected by PCR assay [29]. In
contrast, higher seroprevalence for B. burgdorferi (16 %)
was detected by indirect immunofluorescence assay
among 850 dogs from Monterrey, a city located in the
Northeast of Mexico [23]. A previous study conducted
in the same area reported the presence of a high propor-
tion of ticks infected with B. burgdorferi (sensu stricto),
supporting that the Northeast should be considered a
zone where Lyme disease is endemic [25]. A survey con-
ducted in Mexico City and northeastern regions de-
tected a seroprevalence of 3.43 and 6.2 %, respectively,
among 2346 canine serum samples that were analysed
by ELISA and subsequently confirmed by Western Blot
technique [52]. Higher prevalence (8.2 %), was also
Table 4 Geographical distribution of seroprevalence to CVBD agents among dogs with clinical signs
CVBD-suspect dogs
Region Dogs Dogs infected
(%) [95 % CI]
Positivity (%) [95 % CI] Dogs co-infected
(%) [95 % CI]A Bb Di Ec
Northwestern 203 149 (73.39)** 41 (20.19)* 1 (0.49) 14 (6.89) 140 (68.96)** 43 (21.18)*
[66.5–78.8] [14.8–25.6] [0.0–01.5] [0.0–0.0] [62.6–74.9] [14.8–26.3]
Northeastern 113 59 (52.21) 14 (12.39) 1 (0.88) 16 (14.16)* 43 (38.05) 13 (11.50)
[42.5–61.1] [6.2–19.5] [0.0–2.7] [8.0–20.4] [29.2–47.8] [5.3–17.7]
Northcentral 55 4 (7.27)** 1 (1.81)* 0 (0) 0 (0)* 4 (7.27)** 1 (1.81)*
[1.8–14.5] [0.0–5.5] [0.0–0.0] [0.0–0.0] [1.8–14.5] [0.0–5.5]
Western 82 35 (42.68)* 10 (12.19) 0 (0) 1 (1.22)* 35 (42.68) 11 (13.41)
[32.9–53.7] [6.1–19.5] [0.0–0.0] [0.0–3.7] [31.7–52.4] [6.1–20.7]
Eastern 70 28 (40.0)* 11 (15.71) 1 (1.43) 5 (7.14) 20 (28.57)* 9 (12.86)
[28.6–51.4] [7.1–24.3] [0.0–4.3] [1.4–12.9] [18.6–40.0] [5.7–21.4]
Southcentral 39 12 (30.77)* 2 (5.13) 0 (0) 2 (5.13) 9 (23.08)* 1 (2.56)*
[17.1–46.2] [0.0–12.8] [0.0–0.0] [0.0–12.8] [10.3–35.9] [0.0–7.7]
Southwestern 53 27 (50.94) 12 (22.64) 0 (0) 2 (3.77) 25 (47.17) 11 (20.75)
[37.7–64.2] [11.3–35.8] [0.0–0.0] [0.0–9.4] [34.0–60.4] [11.3–32.1]
Southeastern 107 70 (65.42)* 15 (14.01) 1 (0.93) 17 (15.89)* 57 (53.27) 19 (17.76)
[56.1–73.8] [7.5–20.6] [0.0–3.1] [9.3–23.4] [43.0–62.6] [10.9–25.2]
Mexican states 722 384 (53.18) 106 (14.68) 4 (0.56) 57 (7.89) 333 (46.12) 108 (14.96)
[49.5–56.9] [12.3–17.3] [0.1–1.1] [6.0–10.0] [42.4–49.7] [12.3–17.6]
Abbreviations: A Anaplasma spp., Bb Borrelia burgdorferi (sensu lato), Di Dirofilaria immitis, Ec Ehrlichia canis
* Statistically significant difference (P < 0.05); ** Statistically significant difference (P < 0.0001) to the corresponding national average value of prevalence
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detected by ELISA in 94 dogs from Mexicali (Baja Cali-
fornia), where the known vectors of this disease were
not found [26].
Although little is known about Lyme disease and its
transmission cycle in this country, seroprevalence of
antibodies to B. burgdorferi (sensu lato) in dogs could be
related to human cases of Lyme disease in Mexico [23].
A previous study concluded that the highest potential
for transmission was found in high-altitude and low-
temperature regions, where Ixodes species are known
vectors [28].
Epidemiological data about dirofilariosis in Mexico is
very variable and results from previous studies are diffi-
cult to compare due to differences in the efficacy of the
diverse diagnostic techniques used, size and geographical
origin of the population examined and study season
[22, 27]. The prevalence of heartworm infection at the
national level was previously estimated to be around
7.5 % from Knott and ELISA diagnosis, with highest
prevalence (19.6 %) among dogs from coastal areas [24].
In this study, D. immitis was detected in 5.3 % of all
dogs with the higher percentage of infection (8.9 %) in
the notheastern region. Dirofilaria immitis was not de-
tected in dogs from the northcentral area, which is in
agreement with a previous publication that reported a
low proportion of infection (1.3 %) in post-mortem
examination of 378 dogs from Queretaro, Central
Mexico [27]. Positivity of 7.9 % for D. immitis was found
in the southeastern region in the present study, which is
comparable with previous reported data (8.3 %) in a
study conducted in Yucatan among 676 dogs that were
evaluated by modified Knott’s and thick drop techniques
in blood [53]. However, a study conducted in Celestun,
a coastal locality in Southeast Mexico, detected a preva-
lence of infection as high as 59.8 % among 279 asymp-
tomatic dogs, probably because molecular techniques
were used, the widespread distribution of mosquitoes
and the presence of other mammals that might contrib-
ute to the infection of vectors [54]. The abundance of
Ochlerotatus taeniorhynchus, a potential main vector in
the coastal area, could be the most likely explanation
for the difference in dirofilariasis prevalence observed
between inland and coastal canine populations [54].
Moreover, a high percentage of co-infection with Trypa-
nosoma cruzi, which may interfere significantly with
host responses, has been reported in this region, en-
couraging prophylaxis for dogs [55, 56].
The overall E. canis seroprevalence documented here
(30.8 %) is in accordance with the results of a previous
survey conducted in 25 states of Mexico (33.1 %), which
analysed 2395 canine blood samples by ELISA testing
[57]. Ehrlichia canis accounts in this study for the high-
est prevalence (51.0 %) in the northwestern region,
which is lower than reported before in the State of Sina-
loa (74.5 %), although only 152 dogs infested with ticks
were evaluated by ELISA testing in that study [58]. The
high proportion of infection detected in the southeastern
region (35.4 %) is in agreement with previous studies
conducted in Yucatan [30, 59]. Reported prevalence
among 50 dogs by blood smear evaluation was 4 %,
while 36 % of these dogs were positive by PCR testing
[30]. In the same study, higher values were found by
molecular techniques when only dogs from an animal
shelter were evaluated (45 %). It was presumed that
those dogs were more likely infested by R. sanguineus
(s.l.) and lived at a lower hygiene level [30]. Another sur-
vey conducted in the same area reported similar results
among 120 dogs [59]. Analysis of blood samples using
ELISA testing and blood smear evaluation showed 5.0
and 44.1 % positivity, respectively [59]. However, results
are in contrast to a previous survey performed in Yuca-
tan [60]. That study included 309 stray dogs, which were
evaluated by immunofluorescence antibody test in blood
and indirect immunoperoxidase technique, reporting 8.7
and 8.1 % prevalence of infection, respectively [60]. A
possible explanation could be the diagnostic techniques
used that differed greatly from ELISA testing performed
in the present study. Seroprevalence in the northeastern
region was 22.9 %. A lower prevalence for E. canis (4 %)
has been previously detected by PCR among 100 healthy
Table 5 Positivity to single agents and co-infections among all
dogs included in the study, apparently healthy and
CVBD-suspect dogs
Pathogens Healthy dogs CVBD-suspect dogs Total population
n % n % n %
Single agent 188 19.9* 276 38.2* 475 27.84
A 27 2.9 22 3.0 50 2.93
Bb 0 0 2 0.3 2 0.12
Di 16 1.7 23 3.2 42 2.46
Ec 145 15.4* 229 31.7* 381 22.33
Co-infections 39 4.1* 108 15* 151 8.85
Ec + Di 8 0.8* 23 3.2* 31 1.82
Ec + Bb 0 0 1 0.1 1 0.06
Ec + A 24 2.5* 72 10* 100 5.86
Di + Bb 0 0 0 0 0 0
Di + A 2 0.2 4 0.6 6 0.35
Bb + A 0 0 0 0 0 0
Ec + Di + Bb 0 0 0 0 0 0
Ec + Di + A 5 0.5 7 1.0 12 0.7
Ec + Bb + A 0 0 1 0.1 1 0.06
Di + Bb + A 0 0 0 0 0 0
Ec+Di+ Bb+ A 0 0 0 0 0 0
Abbreviations: A Anaplasma spp., Bb B. burgdorferi (sensu lato), Di D. immitis, Ec E. canis
*Statistically significant difference (P < 0.05)
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dogs infected with ticks, in Coahuila and Durango [31].
This disagreement may be due to the phenomenon black
freezing that occurred during the sampling period of
that study, which was characterized by an abnormally
low average temperature of -5 °C, during four days in
February, which decreased the amount of ticks infesting
dogs. Another factor could be the different diagnostic
techniques used. Additionally, all the dogs included in
that study were healthy dogs, which is in contrast with
the population included in the present survey [31].
Several epidemiological variables were considered in
the present study, in order to evaluate potential associa-
tions with seropositivity to CVBD agents. Prevalence en-
countered for each pathogen varied depending on the
geographical region. Despite this finding, dogs with
travel history to other regions or abroad did not show
significant differences in seroprevalence.
No link was detected between gender and positivity
for CVBD agents, which is in agreement with previous
studies [38, 43, 46, 59], even though distribution of tick
infestation has been reported to be strongly dependent
on female dogs because they are more sedentary than
males when feeding their puppies [29].
Seropositivity value for E. canis in dogs aged one year
or older was significantly higher compared with younger
dogs. It is coincidental with previous studies that pro-
posed the immunological status of the host or the in-
creasing exposure to the vector with age as possible
explanations for this finding [39, 59]. Controversially, a
survey performed in Spain showed a higher proportion
Table 6 Seropositivity for CVBD agents according to the epidemiological variables analysed
Epidemiological
variable (n)
Total population seropositivity (%)
Dogs infected (%) A Bb Di Ec Dogs co-infected (%)
Gender P = 0.205 P = 0.871 P = 0.886 P = 0.772 P = 0.291 P = 0.565
Male (901) 343 (38.07) 89 (9.88) 2 (0.22) 49 (5.44) 288 (31.96) 77 (8.55)
Female (781) 274 (35.08) 79 (10.11) 2 (0.26) 40 (5.12) 231 (29.58) 73 (9.35)
Age P = 0.011 P = 0.958 P = 0.647 P = 0.096 P = 0.014 P = 0.379
< 1 year (82) 19 (23.17) 8 (9.76) 0 (0) 1 (1.22) 15 (18.29) 5 (6.09)
≥ 1 year (1570) 581 (37.01) 156 (9.94) 4 (0.25) 85 (5.41) 489 (31.14) 140 (8.92)
Size P < 0.0001 P = 0.606 P = 0.542 P = 0.001 P = 0.047 P < 0.0001
Small (631) 174 (27.58) 44 (6.97) 0 (0) 13 (2.06) 146 (23.14) 27 (4.28)
Medium (226) 98 (43.36) 25 (11.06) 1 (0.44) 17 (7.52) 80 (35.39) 23 (10.18)
Large (522) 208 (39.85) 55 (10.54) 2 (0.38) 36 (6.89) 172 (32.95) 51 (9.77)
Lifestyle P < 0.0001 P = 0.001 P = 0.214 P < 0.0001 P < 0.0001 P < 0.0001
Indoors (447) 106 (23.71) 27 (6.04) 0 (0) 8 (1.79) 88 (19.69) 17 (3.80)
Outdoors (1159) 487 (42.02) 133 (11.47) 4 (0.34) 81 (6.99) 407 (35.12) 125 (10.78)
Tick contact P < 0.0001 P < 0.0001 P = 0.297 P = 0.002 P < 0.0001 P < 0.0001
Yes (1258) 545 (43.32) 156 (12.40) 4 (0.32) 80 (6.36) 458 (36.40) 141 (11.21)
No (341) 33 (9.68) 4 (1.17) 0 (0.00) 7 (2.05) 25 (7.33) 3 (0.88)
TTI prevention P < 0.0001 P = 0.188 P = 0.069 P = 0.429 P < 0.0001 P = 0.033
Yes (85) 50 (58.82) 12 (14.12) 1 (1.18) 3 (3.53) 49 (57.65) 13 (15.29)
No (1593) 567 (35.59) 155 (9.73) 3 (0.19) 88 (5.52) 468 (29.38) 136 (8.54)
MTI prevention P = 0.180 P = 0.354 P = 0.070 P = 0.484 P = 0.243 P = 0.085
Yes (85) 37 (43.53) 11 (12.94) 1 (1.18) 6 (7.06) 31 (36.47) 12 (14.12)
No (1585) 576 (36.34) 156 (9.84) 3 (0.19) 84 (5.29) 483 (30.47) 137 (8.64)
Clinical signs P < 0.0001 P < 0.0001 P = 0.022 P < 0.0001 P < 0.0001 P < 0.0001
Yes (722) 384 (53.18) 106 (14.68) 4 (0.55) 57 (7.89) 333 (46.12) 108 (14.96)
No (943) 227 (24.07) 58 (6.15) 0 (0) 31 (3.29) 182 (19.3) 39 (4.13)
Travel history P = 0.631 P = 0.680 P = 0.124 P = 0.453 P = 0.572 P = 0.742
Yes (331) 118 (35.65) 35 (10.57) 2 (0.60) 15 (4.53) 98 (29.61) 31 (9.36)
No (1365) 506 (37.07) 134 (9.82) 2 (0.15) 76 (5.57) 426 (31.21) 120 (8.79)
Abbreviations: A Anaplasma spp., Bb B. burgdorferi (sensu lato), Di D. immitis, Ec E. canis, TTI tick-transmitted infections; MTI mosquito-transmitted infections
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of infection for E. canis and B. burgdorferi (sensu lato)
among dogs aged less than one year compared to older
dogs [43]. Comparable to other studies [22, 46], no
significant association between age and positivity for
the rest of the CVBD agents was detected in this
study. By contrast, it has been suggested that the age
of dogs could be an important risk factor for filarial in-
fection, because older dogs are exposed for longer
time periods to mosquito bites than younger dogs, in
endemic areas [39, 56].
As reported previously [22], positivity among small-
breed dogs in this study was significantly lower com-
pared to dogs of medium and large size.
Correlation between the presence of clinical signs and
seropositivity was statistically significant for all of the
CVBD agents analysed. Co-infections were the main
cause of illness detected in CVBD-suspect dogs. Accord-
ing with previous publications, the most common
combinations included Anaplasma spp., D. immitis and
E. canis [39]. A previous report documenting high
prevalence of E. canis infection in Mexico highlighted
that almost half of the population remains subclinically
infected [57]. Thus, a routine serological evaluation
every six months was recommended in dogs presenting
or not clinical signs consistent with CVBD [57]. In con-
trast, no relationship between seropositivity and the sick
status of the dogs was found in studies conducted in
other countries [35, 46]. It has been reported that
clinical signs may vary among and within geographical lo-
cations. Proposed reasons include pathogen strain varia-
tions, dose of infectious organism, breed of dogs
examined, immunological status of the host and concur-
rent infections with other CVBD agents [59].
As described before [30, 57], results showed that dogs
infested with ticks had a higher percentage of seroposi-
tivity for all the pathogens under assessment. This con-
clusion would support the hypothesis that prevalence in
dogs living outdoors should be higher compared to in-
doors, because the increased exposure to the vectors,
but no significant association was detected between B.
burgdorferi (sensu lato) infection and the place where
dogs lived in this study. However, the low number of
positive dogs for borreliosis detected in the study pre-
sented here precludes any conclusion.
Effective preventive measures are not always affordable
in Mexico, so off-label injectable bovine ivermectin for-
mulation and/or tetracycline, doxycycline and imidocarb
are routinely used to treat suspected infections with
CVBD agents [24]. The use of ivermectin promotes a re-
duction in the number of microfilaremic dogs and,
therefore, the source of infection for the mosquito popu-
lation. In addition, tetracyclines are known to destroy
intracellular bacteria of the genus Wolbachia, a filarial
endosymbiont, potentially contributing to a decline
heartworm prevalence [24]. In contrast, dogs that re-
ceived treatment for tick-transmitted infections, such as
tetracycline, doxycycline or imidocarb, showed signifi-
cantly higher seroprevalence for E. canis, in this study.
Similar association was observed previously in an epi-
demiological study conducted in Romania [40]. One
possible explanation for this finding is that most of the
dogs treated for tick-transmitted infections in the study
Table 7 Risk factors for positivity to CVBD agents
Dependent variable risk factor P OR 95 % CI
Positivity
≥ 1 year 0.011 1.94 1.15–3.29
Medium size 0.003 1.54 1.16–2.07
Large size 0.002 1.42 1.14–1.79
Outdoors < 0.0001 2.33 1.82–2.98
Tick contact < 0.0001 7.13 4.89–10.39
TTI prevention < 0.0001 2.58 1.66–4.03
Clinical signs < 0.0001 3.58 2.91–4.42
Positivity to A
Outdoors 0.001 2.02 1.31–3.09
Tick contact < 0.0001 11.93 4.39–32.42
Clinical signs < 0.0001 2.63 1.88–3.67
Positivity to Bb
Clinical signs 0.022 nd nd
Positivity to Di
Medium size 0.035 1.83 1.03–3.24
Large size 0.004 2.04 1.24–3.36
Outdoors < 0.0001 4.12 1.98–8.59
Tick contact 0.002 3.24 1.48–7.08
Clinical signs < 0.0001 2.52 1.61–3.95
Positivity to Ec
≥ 1 year 0.014 2.02 1.14–3.57
Medium size 0.018 1.44 1.06–1.94
Large size 0.009 1.37 1.08–1.74
Outdoors < 0.0001 2.21 1.69–2.87
Tick contact < 0.0001 7.23 4.74–11.04
TTI prevention < 0.0001 3.27 2.10–5.09
Clinical signs < 0.0001 3.58 2.88–4.45
Co-infections
Large size 0.007 1.75 1.16–2.62
Outdoors < 0.0001 3.06 1.82–5.14
Tick contact < 0.0001 14.22 4.50–44.91
TTI prevention 0.033 1.93 1.04–3.58
Clinical signs < 0.0001 4.08 2.79–5.96
Abbreviations: OR odds ratio, CI confidence interval, nd no data
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presented here had detectable infestation with ticks
(76/85), one of the main risk factors for positivity to
CVBD agents. On the other hand, positivity for any
CVBD agent was not associated with the use of macro-
cyclic lactones against canine heartworm infection in
the present survey.
One of the limitations of this study is that a geoeco-
nomic division of the country instead of a climatic div-
ision was used when it was designed. Discrepancies
between both classifications could have influenced the
results obtained for different regions depending on the
location of the veterinary practices. Furthermore, it is
worthy of note that despite the wide geographical distri-
bution of the veterinary centers that participated in this
study, a potential bias derived from selection of the cities
could have influenced the results obtained here.
Conclusions
This study adds valuable epidemiological information
about the current situation of Anaplasma spp., B.
burgdorferi (sensu lato), D. immitis and E. canis across
Mexico. The findings highlight that dogs in Mexico are
at risk of acquiring any of the zoonotic CVBD, which
were under assessment. Veterinarians must be alert
about this situation as they have a key role in the iden-
tification and control of these diseases in dogs and
humans. Nowadays, updated information and products
are widely available, which allows provision of better
and more effective diagnostic and preventive pro-
grammes for dogs.
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